Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06925737
PHASE3

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ifinatamab deruxtecan (also called I-DXd or MK-2400) to treat mCRPC. The goal of this study is to learn if people who receive I-DXd live longer overall and live longer without the cancer growing or spreading than people who receive chemotherapy.

Official title: A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1440

Start Date

2025-05-13

Completion Date

2031-01-06

Last Updated

2026-10-30

Healthy Volunteers

No

Interventions

DRUG

Ifinatamab deruxtecan

Administered via intravenous (IV) infusion every 3 weeks (q3w) until disease progression, unacceptable adverse events (AEs), or other cessation of treatment

DRUG

Docetaxel

Administered via IV infusion q3W until disease progression, unacceptable adverse events (AEs), or other cessation of treatment

DRUG

Prednisone

Oral tablet administered once per day or per approved product label

DRUG

Rescue Medication

Before administering each dose of I-DXd, premedication is required for prevention of nausea and vomiting with a 2 or 3 drug combination regimen (eg, corticosteroids with either a 5-HT3 receptor antagonist or an NK-1 receptor antagonist and other drugs as indicated) per approved product label

Locations (303)

Mayo Clinic in Arizona - Phoenix ( Site 0044)

Phoenix, Arizona, United States

Community Cancer Institute ( Site 0081)

Clovis, California, United States

City of Hope Comprehensive Cancer Center ( Site 0049)

Duarte, California, United States

City of Hope Lennar Foundation Cancer Center ( Site 0059)

Irvine, California, United States

Moores Cancer Center ( Site 0010)

La Jolla, California, United States

Veterans Affairs Long Beach Healthcare System ( Site 0058)

Long Beach, California, United States

Cedars-Sinai Medical Center ( Site 0068)

Los Angeles, California, United States

UCLA Hematology/Oncology - Santa Monica ( Site 0002)

Los Angeles, California, United States

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0006)

Orange, California, United States

Stanford Cancer Center ( Site 0046)

Palo Alto, California, United States

Rocky Mountain Regional Veterans Affairs Medical Center ( Site 0053)

Aurora, Colorado, United States

Yale-New Haven Hospital-Yale Cancer Center ( Site 0050)

New Haven, Connecticut, United States

Veterans Affairs Connecticut Healthcare System ( Site 0062)

West Haven, Connecticut, United States

The GW Medical Faculty Associates ( Site 0057)

Washington D.C., District of Columbia, United States

Washington DC Veterans Affairs Medical Center ( Site 0056)

Washington D.C., District of Columbia, United States

Clermont Oncology Center ( Site 0087)

Clermont, Florida, United States

Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0077)

Jacksonville, Florida, United States

Mid Florida Hematology and Oncology Center ( Site 0086)

Orange City, Florida, United States

Emory University School of Medicine- Grady Campus ( Site 0103)

Atlanta, Georgia, United States

Winship Cancer Institute, Emory University ( Site 0003)

Atlanta, Georgia, United States

Rush University Medical Center-Hematology and Oncology ( Site 0028)

Chicago, Illinois, United States

University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063)

Chicago, Illinois, United States

University of Kentucky Chandler Medical Center ( Site 0048)

Lexington, Kentucky, United States

Greenebaum Comprehensive Cancer Center ( Site 0021)

Baltimore, Maryland, United States

Beth Israel Deaconess Medical Center ( Site 0043)

Boston, Massachusetts, United States

Dana Farber Cancer Institute ( Site 0012)

Boston, Massachusetts, United States

University of Michigan ( Site 0005)

Ann Arbor, Michigan, United States

Henry Ford Hospital ( Site 0035)

Detroit, Michigan, United States

Cancer and Hematology Centers of Western Michigan ( Site 0015)

Grand Rapids, Michigan, United States

Mayo Clinic in Rochester, Minnesota-Mayo Clinic Comprehensive Cancer Center ( Site 0078)

Rochester, Minnesota, United States

HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032)

Saint Louis Park, Minnesota, United States

HealthPartners Cancer Center at Regions Hospital ( Site 0052)

Saint Paul, Minnesota, United States

St. Vincent Frontier Cancer Center-Research ( Site 0037)

Billings, Montana, United States

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island ( Site 0076)

Grand Island, Nebraska, United States

Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026)

Omaha, Nebraska, United States

Comprehensive Cancer Centers of Nevada ( Site 0082)

Las Vegas, Nevada, United States

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016)

Hackensack, New Jersey, United States

University of New Mexico Comprehensive Cancer Center ( Site 0022)

Albuquerque, New Mexico, United States

Icahn School of Medicine at Mount Sinai ( Site 0009)

New York, New York, United States

Great Lakes Cancer Care ( Site 0047)

Williamsville, New York, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0061)

Columbus, Ohio, United States

VA Portland Health Care System ( Site 0038)

Portland, Oregon, United States

Perelman Center for Advanced Medicine ( Site 0067)

Philadelphia, Pennsylvania, United States

Abramson Cancer Center - Penn Medicine ( Site 0079)

Philadelphia, Pennsylvania, United States

Memphis VA Medical Center ( Site 0072)

Memphis, Tennessee, United States

SCRI Oncology Partners ( Site 0074)

Nashville, Tennessee, United States

Henry-Joyce Cancer Clinic ( Site 0042)

Nashville, Tennessee, United States

Parkland Health & Hospital System ( Site 0069)

Dallas, Texas, United States

UT Southwestern Medical Center ( Site 0039)

Dallas, Texas, United States

University of Texas-MD Anderson Cancer Center ( Site 0055)

Houston, Texas, United States

Blue Ridge Cancer Care ( Site 0024)

Roanoke, Virginia, United States

VA Puget Sound Health Care System ( Site 0054)

Seattle, Washington, United States

Fred Hutchinson Cancer Center ( Site 0060)

Seattle, Washington, United States

University Hospital and UW Health Clinics ( Site 0065)

Madison, Wisconsin, United States

Medical College of Wisconsin ( Site 0008)

Milwaukee, Wisconsin, United States

Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0136)

Berazategui, Buenos Aires, Argentina

Instituto de Investigaciones Clinicas Mar del Plata ( Site 0129)

Mar del Plata, Buenos Aires, Argentina

Instituto Alexander Fleming ( Site 0125)

Mar del Plata, Buenos Aires, Argentina

Sanatorio Parque ( Site 0126)

Rosario, Santa Fe Province, Argentina

Centro Medico Dra De Salvo ( Site 0132)

CABA, Argentina

Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0131)

La Rioja, Argentina

Centro Oncologico de Integracion Regional. COIR ( Site 0130)

Mendoza, Argentina

Centro de Diagnostico Investigación y Tratamiento Oncológico (CeDIT) ( Site 0135)

Salta, Argentina

Instituto San Marcos ( Site 0137)

San Juan, Argentina

Blacktown Hospital ( Site 0154)

Blacktown, New South Wales, Australia

Macquarie University-MQ Health Clinical Trials Unit ( Site 0151)

Macquarie University, New South Wales, Australia

Gallipoli Medical Research Ltd ( Site 0153)

Greenslopes, Queensland, Australia

Peter MacCallum Cancer Centre ( Site 0152)

Melbourne, Victoria, Australia

Fiona Stanley Hospital ( Site 0155)

Murdock, Western Australia, Australia

Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 0170)

Linz, Upper Austria, Austria

Klinikum Wels-Grieskirchen GmbH ( Site 0171)

Wels, Upper Austria, Austria

Uniklinikum Salzburg Universitaetsklinik für Innere Medizin III ( Site 0172)

Salzburg, Austria

Hospital Mario Penna ( Site 0179)

Belo Horizonte, Minas Gerais, Brazil

Hospital Universitário Evangélico Mackenzie ( Site 0181)

Curitiba, Paraná, Brazil

Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0184)

Porto Alegre, Rio Grande do Sul, Brazil

Hospital de Base de São José do Rio Preto ( Site 0176)

São José do Rio Preto, São Paulo, Brazil

IPITEC ( Site 0189)

São Paulo, Brazil

IBCC - Núcleo de Pesquisa e Ensino ( Site 0183)

São Paulo, Brazil

Fundación Arturo López Pérez ( Site 0201)

Santiago, Region M. de Santiago, Chile

Bradfordhill ( Site 0200)

Santiago, Region M. de Santiago, Chile

Peking University First Hospital ( Site 1434)

Beijing, Beijing Municipality, China

Shanghai General Hospital ( Site 1449)

Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chonqing Medical University ( Site 1406)

Chongqing, Chongqing Municipality, China

Chongqing University Three Gorges Hospital ( Site 1405)

Chongqing, Chongqing Municipality, China

The First Affiliated Hospital Of Fujian Medical University ( Site 1452)

Fuzhou, Fujian, China

Guangzhou First People's Hospital ( Site 1410)

Guangzhou, Guangdong, China

Sun Yat-Sen University Cancer Center ( Site 1467)

Guangzhou, Guangdong, China

Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 1402)

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center ( Site 1409)

Guangzhou, Guangdong, China

The Fifth Affiliated Hospital of Sun Yat-Sen University ( Site 1459)

Zhuhai, Guangdong, China

Guangxi Medical University Cancer Hospital ( Site 1414)

Nanning, Guangxi, China

Henan Cancer Hospital ( Site 1472)

Zhengzhou, Henan, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1424)

Wuhan, Hubei, China

Hunan Cancer Hospital ( Site 1411)

Changsha, Hunan, China

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 1425)

Nanjing, Jiangsu, China

Jiangsu Province Hospital ( Site 1426)

Nanjing, Jiangsu, China

Zhongda Hospital Southeast University ( Site 1427)

Nanjing, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University ( Site 1438)

Xuzhou, Jiangsu, China

Jilin Province People's Hospital ( Site 1461)

Changchun, Jilin, China

The first affiliated Hospital of Xi an Jiaotong University ( Site 1408)

Xi'an, Shaanxi, China

And 203 more locations on ClinicalTrials.gov